Bank of New York Mellon
XFOR icon

Bank of New York Mellon’s X4 Pharmaceuticals XFOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-344,747
Closed -$81.5K 4257
2025
Q1
$81.5K Hold
344,747
﹤0.01% 4004
2024
Q4
$253K Hold
344,747
﹤0.01% 3841
2024
Q3
$231K Sell
344,747
-124,625
-27% -$83.4K ﹤0.01% 3858
2024
Q2
$272K Buy
469,372
+133,398
+40% +$77.4K ﹤0.01% 3848
2024
Q1
$467K Sell
335,974
-9,980
-3% -$13.9K ﹤0.01% 3557
2023
Q4
$290K Sell
345,954
-128,739
-27% -$108K ﹤0.01% 3807
2023
Q3
$517K Sell
474,693
-3,536
-0.7% -$3.85K ﹤0.01% 3523
2023
Q2
$928K Buy
478,229
+307,036
+179% +$596K ﹤0.01% 3228
2023
Q1
$149K Hold
171,193
﹤0.01% 4002
2022
Q4
$170K Buy
171,193
+31,497
+23% +$31.3K ﹤0.01% 4016
2022
Q3
$239K Hold
139,696
﹤0.01% 3942
2022
Q2
$135K Sell
139,696
-916
-0.7% -$885 ﹤0.01% 4165
2022
Q1
$246K Buy
+140,612
New +$246K ﹤0.01% 4128
2021
Q2
Sell
-54,365
Closed -$468K 4470
2021
Q1
$468K Buy
54,365
+2,065
+4% +$17.8K ﹤0.01% 3718
2020
Q4
$336K Buy
52,300
+3,147
+6% +$20.2K ﹤0.01% 3784
2020
Q3
$333K Buy
49,153
+1,252
+3% +$8.48K ﹤0.01% 3679
2020
Q2
$447K Buy
47,901
+8,969
+23% +$83.7K ﹤0.01% 3535
2020
Q1
$389K Buy
38,932
+6,219
+19% +$62.1K ﹤0.01% 3487
2019
Q4
$350K Buy
32,713
+5,648
+21% +$60.4K ﹤0.01% 3739
2019
Q3
$344K Buy
27,065
+13,075
+93% +$166K ﹤0.01% 3722
2019
Q2
$210K Buy
+13,990
New +$210K ﹤0.01% 3902
2019
Q1
Sell
-25,452
Closed -$59K 4249
2018
Q4
$59K Buy
25,452
+10,056
+65% +$23.3K ﹤0.01% 4036
2018
Q3
$25K Sell
15,396
-225
-1% -$365 ﹤0.01% 4185
2018
Q2
$57K Buy
15,621
+3,259
+26% +$11.9K ﹤0.01% 4068
2018
Q1
$283K Buy
+12,362
New +$283K ﹤0.01% 3811